Abstract

Abstract Glycogen is a natural polysaccharide with a dendrimer structure, in which glucose is frequently branched and polymerized. Functionalizing the numerous non-reducing ends on the molecular surface of glycogen could be expected to enable its use in various fields. We developed a method for enzymatically synthesizing a suitable form of glycogen from sucrose by using sucrose phosphorylase and branching enzyme, both of which belong to the α-amylase family, as well as glucan phosphorylase. We refer to this enzymatically synthesized glycogen as the glucan dendrimer (GD). We then selectively modified the non-reducing ends on the surface of GD particles by using the reaction of glucan phosphorylase with various hexose 1-phosphates. Modifying the non-reducing ends of GD with glucuronic acid or glucosamine added negative and positive charges to the GD particles. In addition, we found that glucuronic acid and/or glucosamine residues at the non-reducing ends can be used to covalently conjugate functional substances, such as sugar chains, proteins, and peptides to the surface of GD particles. GD and modification of its non-reducing ends represent versatile platforms for pharmaceutical applications of polysaccharides.

Highlights

  • Glycogen is a highly branched glucose polysaccharide that serves as a form of energy storage in animals and bacteria

  • We developed a method for enzymatically synthesizing a suitable form of glycogen from sucrose by using sucrose phosphorylase and branching enzyme, both of which belong to the α-amylase family, as well as glucan phosphorylase

  • The glycogen-like polysaccharide synthesized by this method was designated a glucan dendrimer (GD) because it is a spherical, highly branched glucan composed of α-1,4/α-1,6 bonds

Read more

Summary

Introduction

Glycogen is a highly branched glucose polysaccharide that serves as a form of energy storage in animals and bacteria. The molecular surface of glycogen has numerous nonreducing ends. We hypothesized that functionalizing these ends could enable various applications of glycogen in the production of conventional food and cosmetics and pharmaceuticals, among other fields. We introduce our research on the enzymatic synthesis of glycogen-like polysaccharides with tightly controlled molecular weight and particle size and on the technique for selectively modifying their non-reducing ends. AqGP, glucan phosphorylase from Aquifex aeolicus; DDS, drug delivery system; GA, glucoamylase; Gal,

Synthesis of glycogenlike polysaccharides with phosphorylase
Non-reducing end modification of GD
Action on glucuronic 1-phosphate
Action on glucosamine 1-phosphate and mannose 1-phosphate
Action on galactose 1-phosphate and N-acetylglucosamine 1-phosphate
Modification of the non-reducing ends of GD
Functionalization of GD by modification of glucuronic acid and glucosamine
Application of GD to pharmaceutical applications
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call